News

Effects of Public and Charitable Research Funding

20 April 2011

Released today is an OHE study commissioned by Cancer Research UK that explores the interdependence between publicly funded and charity funded medical research. In particular, the…

Incorporating Multiple Criteria in HTA

19 April 2011

This OHE publication is intended to inform and stimulate debate about the way different sorts of evidence and considerations are taken into account in decisions about…

New: Antimicrobial Drug Incentives

6 April 2011

Antimicrobial resistance (AMR) is becoming a major global public health threat. In this new OHE Research Paper, the authors identify barriers to the development of new…

Valuing the National Clinical Assessment Service

1 April 2011

The UK’s National Clinical Assessment Service (NCAS) provides advice to NHS managers about handling performance issues involving doctors, pharmacists and dentists. This post summarises an OHE…

Value-Based Pricing: OHE Comments

23 March 2011

In December 2010, the UK Department of Health released a consultation document to elicit comments on ‘proposals for a new value-based system of pricing medicines which…

Yan Feng

Two Economists Join OHE

10 March 2011

The Office of Health Economics is pleased to announce the appointment of two Economists. Dr Yan Feng specialises in understanding what incentives affect the behaviour of…

Differential Pricing – A Win-Win Solution?

2 March 2011

Summarised in this post is a just-released OHE Occasional Paper that examines the potentially positive impact of differential pricing in Europe and the overall negative effects…

Priority Review Vouchers

New: Priority Review Vouchers and Innovation

17 February 2011

This OHE Seminar Briefing recounts a presentation by Prof Henry Grabowski on US Priority Review Vouchers, intended to provide an incentive for the development of drugs…

Commission214_30Jan

New OHE Commission on Competition in the NHS

14 February 2011

Competition in the NHS is viewed as if it must either be for everything the NHS provides to patients or for nothing. Neither extreme is likely…